https://clinicaltrials.gov/ct2/show/NCT04153409?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Acute Migraine
Interventions : Drug: LAT8881; Drug: Placebo
Sponsor : Lateral Pharma Pty Ltd
Recruiting
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
NCT04153409
Wed, 06 Nov 2019 12:00:00 EST
Last Update Posted: 11/06/19 08:27AM
